Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Olympus Corp (7733 JP): Turnaround Will Take Some Time, Company Taking Positive Baby Steps For Now

Olympus Corp (7733 JP): A Much-Awaited Turnaround On the Cards? One Quarter At a Time

Olympus Corp (7733 JP): Positive Q4FY26 Stabilizes FY26, FY27 Guidance Signals Gradual Recovery

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/olympus-corp" target="_blank" data-smartkarma-citation="entities:356:1" rel="noopener">Olympus Corp (7733 JP)</a> registered 16% YoY rise in revenue to ¥240.4 in Q1FY27 while the adjusted operating profit witnessed 133% YoY increase to ¥30.7B (margin up 640bps to 12.8%).</li>
<li>The company expects FY27 revenue to be ¥1055-1076B (up 4.4%-6.5% YoY), adjusted operating profit to be ¥160.5-179.5B (up 12%-25.3% YoY) and profit to be ¥95.5B-109B (EPS of ¥90-102).</li>
<li>The Q1FY27 earnings is a positive. We now expect a slow, steady and decent recovery starting FY27. We reiterate our bullish stance on the name. </li>
</ul>



Olympus Corp (7733 JP) registered 16% YoY rise in revenue to ¥240.4 in Q1FY27 while the adjusted operating profit witnessed 133% YoY increase to ¥30.7B (margin up 640bps to 12.8%).
The company expects FY27 revenue to be ¥1055-1076B (up 4.4%-6.5% YoY), adjusted operating profit to be ¥160.5-179.5B (up 12%-25.3% YoY) and profit to be ¥95.5B-109B (EPS of ¥90-102).
The Q1FY27 earnings is a positive. We now expect a slow, steady and decent recovery starting FY27. We reiterate our bullish stance on the name. 


Olympus Corp (7733 JP): Q1FY27 Shines, Guidance Reiterated, Recovery On Track